The active ingredient is sodium cromoglycate.
1 ml of drops contains 20 mg of sodium cromoglycan (Natrii cromoglicas).
Excipients: disodium edetate, sorbitol, water for injection.
Always use this medicine exactly as described in the package leaflet or as directed by your doctor or pharmacist.
Children from 4 years and adults: 1 drop in the conjunctival sac 4 times a day.
Avoid touching the dropper tip to the eyes, eyelids, surrounding area and other surfaces.
Treatment with Allergo-KOMOD should not be stopped after the symptoms disappear.
They should be continued until contact with the allergen, i.e. B. pollen or dust stops.
Sodium cromoglycate stabilizes the membranes of mast cells exposed to antigens, preventing their degranulation and the release of various mediators of inflammatory reactions, which are biologically active molecules. They are either synthesized and stored in mast cells (eg, histamine or kinins) and mediate an immediate type I allergic response when released, or synthesized after provoked stimulation (eg, prostaglandins or leukotrienes) and mediate a delayed type IV inflammatory response. As a result, mast cell degranulation is slowed down and histamine release is prevented.
Acute and chronic conjunctivitis, incl. B. pollinous conjunctivitis, spring allergic keratoconjunctivitis.
Do not use Allergo-KOMOD:
if you are allergic (hypersensitive) to sodium cromolyn or any of the other ingredients of this medicine.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Rare side effects :
temporary burning eyes,
sensation of the presence of a foreign body in the eye,
hyperemia and edema of the conjunctiva.
Warnings and Precautions
Contact lenses can be reinserted after 15 minutes if the ophthalmologist decides that the contact lenses can be used.
Store the drug at temperatures below 25°C.
After the first opening of the vial, the drops can be used within 12 weeks.
use of other medicines
Tell your doctor or pharmacist about all medicines you are taking or have recently taken and the doctor you plan to take, including those sold without a prescription.
There are no known interactions of sodium cromoglycate with other topical ophthalmic drugs.
pregnancy and breastfeeding period
The drug should not be used in the first trimester of pregnancy and is not recommended in later pregnancy.
The drug is not recommended for women who are breastfeeding.
The use of the drug in children and adolescents
Do not use on children under 4 years of age.
driving and working machines
Temporary visual disturbances may occur after the use of this medicine, which may slow down reaction time in people who drive or use machines.